Back to Rankings

MNKD

MannKindA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
+
Peers tracked
9
U.S. public peers
Grade Position
Above peers
vs peer average
MNKD vs peer average
90/100
MNKD vs. peer average (A vs. C)
Grade spread
B 2 · C 1 · D 4 · F 1
Graded peers loaded
Coverage
9 graded
100% of tracked

Peer overview

ARDX is the first available peer comparator.

Similarly sized sector company, but not a direct operating peer; useful mainly as a small-cap biopharma risk-appetite reference.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerARDXArdelyx
MNKD
MannKind
ARDX
Ardelyx
Grade
A
C
Momentum
66
8
Value
61
41
Sentiment
54
94
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Mixed

Grade position vs ARDX

MNKD / ARDX
Grade Position
Above peers
MNKD vs. peer average (A vs. C)
90/100
Momentum
66
MNKD
Value
61
MNKD
Sentiment
54
ARDX

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs MNKD
1
ARDX
ARDX
C
60/100
+2
2
CRVS
CRVS
B
80/100
+1
3
AMGN
AMGN
D
40/100
+3
4
JBIO
Jade Biosciences Inc Common
B
80/100
+1
5
AZTA
Azenta Inc Common
D
40/100
+3
ARDX is the first peer returned for this comparison set.